Welcome to our dedicated page for Innovate SEC filings (Ticker: VATE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The INNOVATE Corp. (NYSE: VATE) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, including Form 8-K current reports and other key documents. These filings provide detail on INNOVATE’s portfolio across its Infrastructure, Life Sciences and Spectrum segments and on its capital structure.
Form 8-K current reports for INNOVATE frequently announce quarterly financial results, segment performance and significant events at portfolio companies. Examples include earnings releases for the second and third quarters, updates on DBM Global Inc. cash dividends, and press releases about MediBeacon’s regulatory approvals in the United States and China and R2 Technologies’ growth in Glacial Skin CryoAesthetics platforms.
INNOVATE also uses Form 8-K to disclose financing and refinancing transactions. Recent filings describe exchanges of senior secured notes for new notes with extended maturities, amendments to convertible notes, extensions of the company’s revolving credit agreement, changes to a subordinated secured promissory note with Continental General Insurance Company and extensions of Spectrum and R2 Technologies notes. These documents outline the terms of the new instruments, maturity dates, interest rates and related conditions.
Through this page, users can track how INNOVATE reports revenue by segment, net income or loss by segment and Adjusted EBITDA in its earnings-related filings, as well as how it documents material events such as regulatory approvals and strategic processes linked to debt covenants. Stock Titan’s interface surfaces new filings as they appear on EDGAR and offers AI-powered summaries to help interpret lengthy disclosures, from note exchange terms to segment-level commentary.
Investors researching VATE can review Forms 8-K and related exhibits here to understand INNOVATE’s reporting practices, segment updates, debt profile and the regulatory record of its portfolio companies.
Paul Voigt, Interim CEO of INNOVATE Corp. (VATE), reported the grant of three stock option awards on 09/15/2025. Each award covers 100,000 underlying shares of common stock for a total of 300,000 optioned shares, and each is reported as direct ownership. Exercise prices shown are $5.67, $4.22 and $25.00. The $5.67 exercise price was set at 110% of the 10-day VWAP on the grant date, per the filing. Listed exercisability and expiration dates include ranges through 09/15/2035 for one award and earlier expirations for others. The form is signed by Mr. Voigt and filed on 09/17/2025.
INNOVATE Corp. filed a current report to share a press release about one of its portfolio companies. On September 9, 2025, the company issued a release titled “INNOVATE’s Portfolio Company, R2, has Explosive Growth and Global Reach with Glacial® Skin Continuing to Redefine Aesthetic Innovation,” highlighting developments at R2 and its Glacial® Skin technology.
The press release is attached as Exhibit 99.1 and is treated as “furnished,” not “filed,” meaning it is not subject to certain liability provisions and is not automatically incorporated into other securities offerings unless specifically referenced. No new financial statements or major transactions are described in this report.
INNOVATE Corp. filed a Form D reporting a completed Rule 506(b) exempt offering of newly issued 10.500% Senior Secured Notes due 2027. The filing states the issuer conducted an exchange offer and consent solicitation that exchanged approximately $328.1 million of 8.500% Senior Secured Notes due 2026 for approximately $360.4 million of the new 10.500% Senior Secured Notes. The total offering amount and amount sold are both reported as $360,356,287, with no remaining securities to be sold. The filing lists five investors to date, a $2,000 minimum investment, $0 in sales commissions and finders' fees, and indicates proceeds paid to named officers/directors/promoters as $0. The notice is marked as a new notice with first sale on 2025-07-30 and indicates the offering will not last more than one year.
INNOVATE Corp. (NYSE: VATE) filed an 8-K to disclose preliminary results of its previously announced exchange offer and consent solicitation for its 8.5% Senior Secured Notes due 2026. According to the 31 July 2025 filing (Item 8.01), eligible holders that tendered their notes by 5:00 p.m. ET on 30 July 2025 will receive newly issued 10.5% Senior Secured Notes due 2027 plus the Total Early Exchange Consideration. The company also extended the ability to receive this early-bird consideration through the final Expiration Deadline, aiming to maximise participation. Numeric take-up levels and revised terms were not included in the filing but are expected in Exhibit 99.1 (press release). No other financial statements were furnished. The transaction lowers near-term refinancing pressure by pushing maturity out one year, but comes at a higher coupon, signalling a higher cost of capital.